Acute Myeloid Leukemia
Showing NaN - NaN of 83
Acute Myeloid Leukemia, MDS Trial in United States (CG-806)
Recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
-
Duarte, California
- +9 more
Mar 4, 2022
Acute Myeloid Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Worldwide (FT-2102 (olutasidenib),
Active, not recruiting
- Acute Myeloid Leukemia
- +2 more
- FT-2102 (olutasidenib)
- +2 more
-
Los Angeles, California
- +59 more
Mar 2, 2022
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, MDS Trial in United States (CliniMacs TCR alpha-beta-Biotin system)
Enrolling by invitation
- Acute Lymphoblastic Leukemia
- +2 more
- CliniMacs TCR alpha-beta-Biotin system
-
Los Angeles, California
- +9 more
Feb 10, 2022
Acute Myeloid Leukemia Trial in Worldwide (Magrolimab, Venetoclax, Azacitidine)
Active, not recruiting
- Acute Myeloid Leukemia
- Magrolimab
- +6 more
-
Duarte, California
- +25 more
Feb 4, 2022
Acute Myeloid Leukemia, Acute Lymphoid Leukemia, MDS Trial in United States (TregGraft (Orca-T))
Recruiting
- Acute Myeloid Leukemia
- +4 more
- TregGraft (Orca-T)
-
Duarte, California
- +13 more
Oct 28, 2021
Acute Myeloid Leukemia Trial in United States (AMV564, AMV564 in combination with pembrolizumab)
Completed
- Acute Myeloid Leukemia
- AMV564
- AMV564 in combination with pembrolizumab
-
San Francisco, California
- +9 more
Oct 11, 2021
Acute Myeloid Leukemia Trial in Worldwide (guadecitabine, Treatment Choice (TC))
Completed
- Acute Myeloid Leukemia
- guadecitabine
- Treatment Choice (TC)
-
Los Angeles, California
- +94 more
Sep 5, 2021
Acute Myeloid Leukemia Trial in Singapore, United States (Cytarabine, Daunorubicin, Etoposide)
Hematopoietic Stem Cell Transplantation, Acute GVHD, Acute Myeloid Leukemia Trial in United States (CD24Fc, Placebo,
Active, not recruiting
- Hematopoietic Stem Cell Transplantation
- +4 more
- CD24Fc
- +3 more
-
Duarte, California
- +3 more
Jul 19, 2021
Acute Myeloid Leukemia Trial in Chicago (Cytarabine, Idarubicin, Omacetaxine mepesuccinate)
Terminated
- Acute Myeloid Leukemia
- Cytarabine
- +2 more
-
Chicago, IllinoisUniversity of Illinois at Chicago
Jul 1, 2021
Classical Hodgkin Lymphoma, B-cell Non-Hodgkin Lymphoma, Acute Myeloid Leukemia Trial in Chicago (Pembrolizumab)
Recruiting
- Classical Hodgkin Lymphoma
- +3 more
-
Chicago, IllinoisUniversity of Chicago
Jun 29, 2021
Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in France, United States (oral
Completed
- Myelodysplastic Syndrome
- +2 more
- oral rigosertib
- Azacitidine
-
Gilbert, Arizona
- +12 more
Jun 15, 2021
Acute Myeloid Leukemia, Lymphoblastic Leukemia, Acute Leukemia Trial in Chicago (IM-TMI (3Gy), IM-TMI (6Gy), IM-TMI (9Gy))
Completed
- Acute Myeloid Leukemia
- +4 more
- IM-TMI (3Gy)
- +3 more
-
Chicago, IllinoisUniversity of Illinois at Chicago
May 18, 2021
Acute Myeloid Leukemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome Trial in Chicago (Laboratory Biomarker
Completed
- Acute Myeloid Leukemia
- +4 more
- Laboratory Biomarker Analysis
- Selinexor
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
May 12, 2021
Acute Myeloid Leukemia, Adult Acute Monoblastic Leukemia, Adult Acute Monocytic Leukemia Trial in Canada, Puerto Rico, United
Completed
- Acute Myeloid Leukemia
- +27 more
- Caspofungin Acetate
- +2 more
-
Birmingham, Alabama
- +178 more
Mar 26, 2021
Acute Myeloid Leukemia Trial in Canada, United States (Midostaurin, Standard of Care)
Completed
- Acute Myeloid Leukemia
- Midostaurin
- Standard of Care
-
La Jolla, California
- +18 more
Mar 12, 2021
Acute Myeloid Leukemia Trial in United States (Pracinostat, Azacitidine)
Completed
- Acute Myeloid Leukemia
-
Duarte, California
- +16 more
Jan 21, 2021
Acute Myeloid Leukemia Trial in Chicago (Cytarabine, Mitoxantrone Hydrochloride, Selinexor)
Completed
- Acute Myeloid Leukemia
- Cytarabine
- +2 more
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
Apr 6, 2020
Acute Myeloid Leukemia Trial in Worldwide (PF-04449913, Low dose ARA-C (LDAC), Decitabine)
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in United States (ADCT-301)
Terminated
- Acute Myeloid Leukemia
- Acute Lymphoblastic Leukemia
-
Atlanta, Georgia
- +10 more
Feb 12, 2020